Schedule 13G ownership disclosure

Celldex Therapeutics Inc

Common Stock, par value $.001 · CUSIP: 15117B202

Event date: 2025-04-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • COMMODORE CAPITAL LP

    Shares: 3,350,000.00 · Class: 5.0%

  • Commodore Capital Master LP

    Shares: 3,350,000.00 · Class: 5.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001641172-25-003604
Form type
SCHEDULE 13G
Filer
Commodore Capital LP
CIK
CIK 1831942
Filed
Apr 10, 2025
Reporting period
Apr 03, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub